SG11202009687PA - A method of inducing or improving wound healing properties of mesenchymal stem cells - Google Patents

A method of inducing or improving wound healing properties of mesenchymal stem cells

Info

Publication number
SG11202009687PA
SG11202009687PA SG11202009687PA SG11202009687PA SG11202009687PA SG 11202009687P A SG11202009687P A SG 11202009687PA SG 11202009687P A SG11202009687P A SG 11202009687PA SG 11202009687P A SG11202009687P A SG 11202009687PA SG 11202009687P A SG11202009687P A SG 11202009687PA
Authority
SG
Singapore
Prior art keywords
mesenchymal stem
cell population
stem cell
cells
umbilical cord
Prior art date
Application number
SG11202009687PA
Other languages
English (en)
Inventor
Toan Thang Phan
Gavin Tan
Original Assignee
Cellresearch Corp Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellresearch Corp Pte Ltd filed Critical Cellresearch Corp Pte Ltd
Publication of SG11202009687PA publication Critical patent/SG11202009687PA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
SG11202009687PA 2018-04-12 2019-04-12 A method of inducing or improving wound healing properties of mesenchymal stem cells SG11202009687PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862656531P 2018-04-12 2018-04-12
PCT/SG2019/050204 WO2019199234A1 (en) 2018-04-12 2019-04-12 A method of inducing or improving wound healing properties of mesenchymal stem cells

Publications (1)

Publication Number Publication Date
SG11202009687PA true SG11202009687PA (en) 2020-10-29

Family

ID=68163253

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009687PA SG11202009687PA (en) 2018-04-12 2019-04-12 A method of inducing or improving wound healing properties of mesenchymal stem cells

Country Status (12)

Country Link
EP (1) EP3775163A4 (cg-RX-API-DMAC7.html)
JP (2) JP7541730B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200143399A (cg-RX-API-DMAC7.html)
CN (2) CN120608017A (cg-RX-API-DMAC7.html)
AU (1) AU2019250653B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020020092A2 (cg-RX-API-DMAC7.html)
CA (1) CA3095490A1 (cg-RX-API-DMAC7.html)
PH (1) PH12020551658A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202009687PA (cg-RX-API-DMAC7.html)
TW (1) TWI882956B (cg-RX-API-DMAC7.html)
WO (1) WO2019199234A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202005967B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4040957A4 (en) * 2019-10-08 2023-11-01 CellResearch Corporation Pte. Ltd. MESENCHYMAL STEM CELL STORAGE OR TRANSPORT FORMULATION AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2020362379A1 (en) * 2019-10-08 2022-04-07 Cellresearch Corporation Pte. Ltd. A method of assessing wound healing potency of a mesenchymal stem population and related methods of selecting mesenchymal stem cells and identifying tissue as starting material for producing a mesenchymal stem cell population
WO2021257073A1 (en) * 2020-06-17 2021-12-23 Joy Kong Method for producing mesenchymal stem cells from neonatal stem cells
WO2022004938A1 (ko) * 2020-06-30 2022-01-06 주식회사 미래셀바이오 유사 중간엽 줄기세포의 제조방법
CN114196626A (zh) * 2022-02-16 2022-03-18 北京国卫生物科技有限公司 脐带间充质干细胞及其分离培养扩增方法
WO2024107102A1 (en) * 2022-11-17 2024-05-23 Cellresearch Corporation Pte. Ltd. Use of conditioned medium derived from cultivation of mesenchymal stem cells of the umbilical cord for inducing, stimulating and promoting hair growth and regeneration
AU2022488222A1 (en) * 2022-12-09 2025-06-19 Cellresearch Corporation Pte. Ltd. Use of conditioned medium of cord lining mesenchymal stem cells for healing and/or preventing the formation and/or recurrence of a wound or a damaged skin area

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288293A1 (en) 2001-08-30 2003-03-05 Norio Sakuragawa Human neural stem cells originated from human amniotic mesenchymal cell layer
JP4790592B2 (ja) 2003-02-11 2011-10-12 ダビース,ジヨン・イー ヒト臍帯のウォートンジェリーからの前駆細胞
AR044688A1 (es) * 2003-06-12 2005-09-21 Euro Celtique Sa Agentes terapeuticos utiles para el tratamiento del dolor
NZ553695A (en) 2004-08-16 2009-10-30 Cellres Corp Pte Ltd Isolation of stem/progenitor cells from amniotic membrane of umbilical cord
CN101189341B (zh) * 2005-04-04 2016-10-19 纳幕尔杜邦公司 用于制备抗真菌病原体的植物的多核苷酸和方法
CN101330935B (zh) * 2005-10-21 2013-11-13 细胞研究私人有限公司 自脐带羊膜分离和培养干/祖细胞及其分化的细胞的应用
JP4569711B2 (ja) * 2006-04-14 2010-10-27 和光純薬工業株式会社 複数溶液導入構造、該構造を有する微小流体装置及び溶液導入法
WO2008123918A1 (en) * 2007-04-02 2008-10-16 The General Hospital Corporation Cellular compositions for the treatment of kidney disease and uses thereof
KR101138091B1 (ko) 2011-08-31 2012-04-24 세원셀론텍(주) 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제
WO2013059528A2 (en) * 2011-10-18 2013-04-25 City Of Hope Encapsulated diagnostics and therapeutics in nanoparticles-conjugated to tropic cells and methods for their use
US9670488B2 (en) * 2011-11-04 2017-06-06 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of met by double stranded RNA
CN103301154B (zh) * 2013-04-19 2014-12-17 胡祥 脐带间充质干细胞在制备治疗红斑狼疮的制剂中的用途
CN104630142B (zh) * 2015-02-06 2018-06-05 广州赛莱拉干细胞科技股份有限公司 一种牛脐带间充质干细胞的分离及培养方法
EP3385368B1 (en) 2015-12-03 2023-03-01 Takara Bio Inc. Method for producing mesenchymal stem cells
WO2017096607A1 (zh) 2015-12-11 2017-06-15 郭镭 一种从脐带外层羊膜组织中分离提取hUC-MSC的方法
CN105420179A (zh) * 2015-12-17 2016-03-23 斯坦姆(天津)生物技术研究有限公司 一种从脐带和胎盘羊膜组织同时提取上皮细胞和间充质干细胞的方法
CN106119191A (zh) * 2016-07-05 2016-11-16 四川华皓生物科技有限公司 一种胎盘绒毛板间充质干细胞及临床化制备方法
CN106377544A (zh) * 2016-09-30 2017-02-08 广州赛莱拉干细胞科技股份有限公司 脐带间充质干细胞上清液在制备治疗口腔溃疡药物中的应用及漱口液和其制备方法
TWI773693B (zh) 2016-10-05 2022-08-11 新加坡商細胞研究私人有限公司 從臍帶的羊膜分離間質幹細胞的方法、從臍帶的羊膜分離的間質幹細胞群以及用於從臍帶的羊膜分離間質幹細胞的細胞培養基
WO2019199230A1 (en) 2018-04-09 2019-10-17 Cellresearch Corporation Pte. Ltd. A method of transporting mesenchymal stem cells by means of a cell culture medium and a method of administering stem cells to wounds

Also Published As

Publication number Publication date
EP3775163A1 (en) 2021-02-17
JP7541730B2 (ja) 2024-08-29
JP7876213B2 (ja) 2026-06-19
KR20200143399A (ko) 2020-12-23
JP2021526125A (ja) 2021-09-30
JP2024069365A (ja) 2024-05-21
TW202012618A (zh) 2020-04-01
EP3775163A4 (en) 2022-03-09
PH12020551658A1 (en) 2021-07-26
ZA202005967B (en) 2021-08-25
BR112020020092A2 (pt) 2021-02-17
CA3095490A1 (en) 2019-10-17
WO2019199234A1 (en) 2019-10-17
CN112262211B (zh) 2025-05-09
AU2019250653B2 (en) 2025-06-19
AU2019250653A1 (en) 2020-10-15
TWI882956B (zh) 2025-05-11
CN120608017A (zh) 2025-09-09
CN112262211A (zh) 2021-01-22

Similar Documents

Publication Publication Date Title
ZA202005967B (en) A method of inducing or improving wound healing properties of mesenchymal stem cells
GB201712165D0 (en) Wound dressing and method of manufacture
SMT202300457T1 (it) Linguaggio di soluzione naturale
GB201804514D0 (en) Treatment of pyroptosis
GB201806072D0 (en) Methods of manufacture
SG10201914102UA (en) Stem cells for wound healing
IL276929A (en) A method for increasing plant efficiency
ZA202106233B (en) Method of improving sleep
GB201805447D0 (en) Wound healing
GB201804594D0 (en) Bonegraft substituteand method of manufacture
IL290983A (en) Treatment methods
GB201802839D0 (en) Method of manufacture
GB201804515D0 (en) Treatment of necroptosis
IL288353A (en) Methods of treating cholangiocarcinoma
IL287250A (en) treatment method
GB201805287D0 (en) Haematoietic stem cell treatment
GB201805904D0 (en) Methods of Manufacture
GB202005231D0 (en) Method of mimimising patient risk
GB201817985D0 (en) Stem cell line for treatment of various medical conditions
PL3431656T3 (pl) Sposób obróbki kamieni tłuczniowych
ZA201800600B (en) Method of wound healing
GB201918853D0 (en) Methods of treatment
SG11202104087QA (en) Stem cell therapy
EP3362044A4 (en) TREATMENT AGAINST INFECTION COMPOSED OF MENSTRUAL BLOOD STEM CELLS
SG11202102240YA (en) Methods of treating psoriasis